Search Results 401-410 of 17430 for Oncogene
Activating Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation (any G12, G13, Q61) confirmed by Clinical Laboratory Improvement Amendments (CLIA)- ...
Kaufmann's ongoing studies are designed to improve understanding of the regulation of this pathway and particularly its inhibition by oncogenes in cancer cells.
Current work on childhood, adolescent and young adult cancers runs the gamut from identifying oncogenic drivers and studying malignant transformation to ...
The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...
“There are patients in whom we've seen alterations in genes that we can do something about right now, like the oncogenes BRAF or HER2,” said Dr. Mody, who ...
... oncogenic potential. Co-authors of the paper include Barbara Schroeder, Ph.D. of Mayo Clinic, Javier Menendez, Catalan, Institute of Oncology, Susan Peirce ...
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...
* Nonsquamous participants must not have documented targetable oncogenic mutation or actionable genetic alterations (AGAs) for which there is a standard of ...
Rochester, Minn. This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or ...
Rosenfeld's lab has shown that glioblastomas consist of subpopulations of tumor cells that depend on different oncogenic kinases, with each subpopulation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.